Catalyst Pharmaceutical CPRX Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's deferred taxes?
- Catalyst Pharmaceutical (CPRX) reported deferred taxes of $2.34M in Q1 2026.
- How has Catalyst Pharmaceutical's deferred taxes changed year-over-year?
- Catalyst Pharmaceutical's deferred taxes increased by 0.6% year-over-year, from $2.32M to $2.34M.
- What is the long-term trend for Catalyst Pharmaceutical's deferred taxes?
- Over 2 years (2021 to 2023), Catalyst Pharmaceutical's deferred taxes has grown at a 41.7% compound annual growth rate (CAGR), from -$9.32M to $18.7M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.